返回
Sarcopenia
DOI:10.1038/s41572-024-00550-w.png)
摘要
En 中文
Sarcopenia is the accelerated loss of skeletal muscle mass and function commonly, but not exclusively, associated with advancing age. It is observed across many species including humans in whom it can lead to decline in physical function and mobility as well as to increased risk of adverse outcomes including falls, fractures and premature mortality. Although prevalence estimates vary because sarcopenia has been defined in different ways, even using a conservative approach, the prevalence is between 5% and 10% in the general population. A life course framework has been proposed for understanding not only the occurrence of sarcopenia in later life but also influences operating at earlier life stages with potentially important implications for preventive strategies. Harnessing progress in understanding the hallmarks of ageing has been key to understanding sarcopenia pathophysiology. Considerable convergence in approaches to diagnosis of sarcopenia has occurred over the last 10 years, with a growing emphasis on the central importance of muscle strength. Resistance exercise is currently the mainstay of treatment; however, it is not suitable for all. Hence, adjunctive and alternative treatments to improve quality of life are needed. An internationally agreed approach to definition and diagnosis will enable a step change in the field and is likely to be available in the near future through the Global Leadership Initiative in Sarcopenia.
Keyword:
QUALITY-OF-LIFE
HUMAN SKELETAL-MUSCLE
ASIAN WORKING GROUP
LEAN BODY-MASS
GRIP STRENGTH
OLDER-ADULTS
PHYSICAL PERFORMANCE
VITAMIN-D
PROTEIN-INTAKE
METAANALYSIS
期刊
N
IF:
60.6
论文数:
650
被引数:
3.8W
机构
引用论文
How do we define and measure sarcopenia? A meta-analysis of observational studies
AGE AND AGEING
IF7.1
Validity and Reliability of Tools to Measure Muscle Mass, Strength, and Physical Performance in Community-Dwelling Older People: A Systematic Review测量社区老年人肌肉质量,力量和身体表现的工具的有效性和可靠性: 系统综述
SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomesSARC-F: 预测肌肉减少症患者功能不良结局风险的症状评分
Myoprotective Whole Foods, Muscle Health and Sarcopenia: A Systematic Review of Observational and Intervention Studies in Older Adults
NUTRIENTS
IF5
Roles of nutrition in muscle health of community-dwelling older adults: evidence-based expert consensus from Asian Working Group for Sarcopenia营养在社区老年人肌肉健康中的作用: 亚洲肌肉减少症工作组的循证专家共识
A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus人类免疫缺陷病毒患者肌少症患病率及相关因素的系统评价

